Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

dpp-cndac

Known as: 5'-O-dipalmitoylphosphatidyl 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine, dipalmitoylphosphatidyl-CNDAC 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
  • T. Asai, N. Oku
  • Methods in molecular biology
  • 2010
  • Corpus ID: 43829298
Liposomal oligopeptides are one of the promising nanocarriers to deliver a drug, DNA or siRNA to target tissues. In this chapter… Expand
2008
2008
Causing damage to angiogenic vessels is a promising approach for cancer chemotherapy. The present study is a codification of a… Expand
Highly Cited
2004
Highly Cited
2004
Because membrane type‐1 matrix metalloproteinase (MT1‐MMP) is expressed specifically on the angiogenic endothelium as well as… Expand
Highly Cited
2002
Highly Cited
2002
We previously reported that liposomalized 5′‐O‐dipalmitoylphosphatidyl 2′‐C‐cyano‐2′‐deoxy‐1‐β‐D‐arabino‐pentofuranosylcytosine… Expand
2001
2001
2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine (CNDAC) is a potent anti-cancer agent, and we previously observed… Expand
2000
2000
UNLABELLED Liposomes can serve as a sustained-release carrier system, permitting the spinal delivery of large opioid doses… Expand
1998
1998
A novel method was utilized to accurately measure the z- component of the nuclear hyperfine interaction tensor, Azz, of a chain… Expand
  • figure 1
  • figure 3
  • figure 2
  • table 1
  • figure 4
1998
1998
We previously synthesized the 5'-O-diacylphosphatidyl derivative of 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine… Expand
1978
1978
Radiotracer studies of calcium adsorption to dipalmitoylphosphatidyl-alkanolamine monolayers measured at various temperatures… Expand